Fast MRI Compared to Routine Clinical MRI in Children With Brain Tumor

Sponsor
Karolinska University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05776602
Collaborator
(none)
50
33.1

Study Details

Study Description

Brief Summary

This study aims to assess the diagnostic performance of a new fast MRI sequence named Neuromix compared to routine clinical MRI for brain tumor in pediatric patients

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Fast MRI (Neuromix)

Detailed Description

The study aims to assess the diagnostic performance of fast MR sequence for the radiological evaluation of brain tumor in comparison to routine clinical MRI in a pediatric population. The primary outcome is the depiction and characterization of brain tumor pathology. Sensitivity, specificity, AUC and intra-/ interreader agreement for the diagnostic performance of Neuromix compared to cMRI will be obtained.

Secondary outcomes will also include the assessment of diagnostic image quality and image artifacts.

The study population will consist of subjects aged 0-18 with a suspected or diagnosed brain tumor referred for routine MRI examination of the brain.

Study subjects will be investigated during the same day at 3T MR with Neuromix sequence in addition to the routine MRI examination.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Fast MRI Compared to Routine Clinical MRI in Children With Brain Tumor
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Pediatric patients with suspected or confirmed brain tumor

New method och standard MRI in clinical care

Diagnostic Test: Fast MRI (Neuromix)
Diagnostic performance, correlation, agreement

Outcome Measures

Primary Outcome Measures

  1. Diagnostic performance [Through study completion, an average of 1 year]

    AUC, area under the curve for the comparison of the new method against the reference standard

Secondary Outcome Measures

  1. Imaging artifacts [through study completion, an average of 1 year]

    Image artifacts on both methods

  2. Imaging quality [through study completion, an average of 1 year]

    Image quality on both methods

  3. Correlation [through study completion, an average of 1 year]

    Correlation between readers and methods

  4. Agreement [through study completion, an average of 1 year]

    Agreement between readers and methods

  5. Sensitivity [through study completion, an average of 1 year]

    Sensitivity of the new method against the reference standard

  6. Specificity [through study completion, an average of 1 year]

    Specificity of the new method against the reference standard

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 18 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 0-18 years.

  • Pediatric subjects with diagnosed brain tumor

  • Referral routine MRI study.

Exclusion Criteria:
  • MRI planned without sedation

  • Aborted MR exam

  • Unstable patient

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Karolinska University Hospital

Investigators

  • Principal Investigator: Anna Falk Delgado, Ass Prof, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Anna Falk Delgado, MD, associate professor, Karolinska University Hospital
ClinicalTrials.gov Identifier:
NCT05776602
Other Study ID Numbers:
  • ALF Project 520205
First Posted:
Mar 20, 2023
Last Update Posted:
Mar 20, 2023
Last Verified:
Mar 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Anna Falk Delgado, MD, associate professor, Karolinska University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 20, 2023